Our findings showed that LGR5 was progressively expressed in cervical carcinogenesis, and LGR5 expression promoted the proliferation and tumor formation of cervical cancer cells by potentiating the Wnt/β-catenin pathway, indicating that LGR5 may be a potential therapeutic target in cervical cancer. The gene discussed is LGR5; the disease is cervical cancer.